Sensitivity Analyses of Event Free and Overall Survival in High-Risk Neuroblastoma Patients Receiving Eflornithine (DFMO) Maintenance Treatment with Matched External Controls, Giselle Saulner Sholler, William Ferguson, Genevieve Bergendahl, Thomas Clinch, Elizabeth Lorenzi, Donald A. Berry, Javier Oesterheld, Valerie I. Brown, Don E. Eslin, Derek Hanson, Virginia L. Harrod, Michael S. Isakoff, Deanna S Mitchell, William Roberts, Randal K. Wada, Peter Zage, Jaqueline Kraveka, 2023 ANR Annual Meeting, Amsterdam, Netherlands